Bacillus Calmette-Guérin cell-wall skeleton enhances the killing activity of cytotoxic lymphocyte-activated human dendritic cells transduced with the prostate-specific antigen gene

BJU International

Volumn 104, Issue 11, 2009, Pages 1766-1773

  Fujii, Reona ^a   Iwahashi, Makoto ^a   Kikkawa, Kazuro ^a   Inagaki, Takeshi ^a   Kohjimoto, Yasuo ^a   Ojima, Toshiyasu ^a   Mori, Takashi ^a   Kuramoto, Tomomi ^a   Nishizawa, Satoshi ^a   Azuma, Ichiro ^b   Yamaue, Hiroki ^a   Shinka, Toshiaki ^a   Hara, Isao ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b HOKKAIDO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

BCG; Cell wall skeleton; Cytotoxic lymphocytes; Dendritic cell; Prostate cancer

Indexed keywords

ADENOVIRUS VECTOR; ANTIBODY; BCG VACCINE; CD8 ANTIBODY; CELL WALL SKELETON; CHROMIUM 51; HLA ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1 ANTIBODY; PHYTOHEMAGGLUTININ; PROSTATE SPECIFIC ANTIGEN; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; BLAST CELL; CANCER CELL; CANCER CELL CULTURE; CD8+ T LYMPHOCYTE; CELL KILLING; CELL MATURATION; CELL STRAIN LNCAP; CELLULAR IMMUNITY; CENTRIFUGATION; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC LYMPHOCYTE; CYTOTOXICITY; DENDRITIC CELL; EMBRYO; FEMALE; FLOW CYTOMETRY; GENETIC TRANSDUCTION; HAPLOTYPE; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; NORMAL HUMAN; PRIORITY JOURNAL; PROSTATE CANCER;

ADENOVIRIDAE; ANTIGENS, CD8; CELL LINE, TUMOR; CELL WALL SKELETON; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE THERAPY; GENETIC VECTORS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOTHERAPY; MALE; MYCOBACTERIUM BOVIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; T-LYMPHOCYTES, CYTOTOXIC; TRANSDUCTION, GENETIC;

EID: 70449334513     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2009.08703.x     Document Type: Article

References (29)

1. American Cancer Society. Cancer Facts and Figures, 2004. Atlanta : American Cancer Society, 2005
2. Paulson DF. Impact of radical prostatectomy in the management of clinically localized disease. J Urol 1994 152 : 1826 1830
3. Landstorm M, Damber JE, Bergh A. Prostatic tumor regrowth after initially successful castration therapy may be related to a decreased apoptotic cell death rate. Cancer Res 1994 54 : 4281 4
4. Chodak GW, Keane T, Klotz L. Critical evaluation of hormonal therapy for carcinoma of the prostate. Urology 2002 60 : 201 208
5. Keating NL, O'Malley AJ, Smith MR. Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer. J Clin Oncol 2006 24 : 4448 4456
6. Hsu FJ, Benike C, Levy R et al. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat Med 1996 2 : 52 8
7. Nestle FO, Alijagic S, Schadendorf D et al. Vaccination of melanoma patients with peptide or tumor lysate-pulsed dendritic cells. Nat Med 1998 4 : 328 332
8. Small EJ, Fratesi P, Valone FH. et al. Immunotherapy of hormone-refractory prostate cancer with antigen-loaded dendritic cells. J Clin Oncol 2000 18 : 3894 3903
9. van der Bruggen P, Traversari C, Boon T et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 1991 254 : 1643 1647
10. Banchereau J, Palucka AK. Dendritic cells as therapeutic vaccines against cancer. Nat Rev Immunol 2005 5 : 296 306 (Pubitemid 40516155)
11. Nakamura M, Iwahashi M, Yamaue H et al. Dendritic cells genetically engineered to simultaneously express endogenous tumor antigen and granulocyte macrophage colony-stimulating factor elicit potent therapeutic antitumor immunity. Clin Cancer Res 2002 8 : 2742 2749
12. Tsuji S, Matsumoto M, Seya T et al. Maturation of human dendritic cells by cell wall skeleton of Mycobacterium bovis Bacillus Calmette-Guerin. Involvement of Toll-like receptors. Infect Immun 2000 68 : 6883 6890
13. Sanda MG, Restifo NP, Simons JW et al. Molecular characterization of defective antigen processing in human prostate cancer. J Natl Cancer Inst 1995 87 : 280 285
14. Ueda K, Iwahashi M, Yamaue H et al. Enhanced selective gene expression by adenovirus vector using Cre/loxP regulation system for human carcinoembryonic antigen-producing carcinoma. Oncology 2000 59 : 255 265
15. Nishimura N, Nishioka Y, Sone S et al. Enhanced efficiency by centrifugal manipulation of adenovirus-mediated interleukin 12 gene transduction into human monocyte-derived dendritic cells. Hum Gene Ther 2001 12 : 333 346 (Pubitemid 32186646)
16. Iwahashi M, Tsunoda T, Yamaue H et al. Defective autologous mixed lymphocyte reaction (AMLR) and killer activity generated in the AMLR in cancer patients. Int J Cancer 1992 51 : 67 71
17. Terasawa H, Iwahashi M, Yamaue H et al. Antitumor effects of interleukin-2 gene modified fibroblasts in an orthotopic colon cancer model. Jpn J Cancer Res 1999 90 : 1000 1006
18. Terasawa H, Tsang K-Y, Schlom J et al. Identification and characterization of a human agonist cytotoxic T-lymphocyte epitope of human prostate-specific antigen. Clin Cancer Res 2002 8 : 41 53
19. Pérez-Díez A, Butterfield LH, Li L, Chakraborty NG, Economou JS, Mukherji B. Generation of CD8+ and CD4+ T-cell response to dendritic cells genetically engineered to express the MART-1/Melan-A gene. Cancer Res 1998 58 : 5305 5309
20. Diebold SS, Cotton M, Zenke M et al. MHC class II presentation of endogenously expressed antigens by transfected dendritic cells. Gene Ther 2001 8 : 487 493
21. Kündig TM, Bachmann MF, Zinkernagel RM et al. On the role of antigen in maintaining cytotoxic T-cell memory. Proc Natl Acad Sci USA 1996 93 : 9716 9723
22. Heiser A, Boczkowski D, Gilboa E et al. Human dendritic cells transfected with RNA encoding prostate-specific antigen stimulate prostate-specific CTL responses in vitro. J Immunol 2000 164 : 5508 5514
23. Nikitina EY, Clark JI, Gabrilovich DI et al. Dendritic cells transduced with full-length wild-type p53 generate antitumor cytotoxic T lymphocytes from peripheral blood of cancer patients. Clin Cancer Res 2001 7 : 127 135
24. Ojima T, Iwahashi M, Yamaue H et al. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen. Int J Oncol 2006 28 : 947 953
25. Tuettenberg A, Jonuleit H, Enk AH et al. Priming of T cells with Ad-transduced DC followed by expansion with peptide-pulsed DC significantly enhances the induction of tumor-specific CD8+ T cells: implications for an efficient vaccination strategy. Gene Ther 2003 10 : 243 250
26. Robertson MJ, Cameron C, Ritz J et al. Costimulation of human natural killer cell proliferation: role of accessory cytokines and cell contact-dependent signals. Nat Immun 1996 15 : 213 226
27. Lewis CE, Ramshaw AL, McGee JO et al. Basic fibroblast growth factor and interleukins 4 and 6 stimulate the release of IFN-? by individual NK cells. Cell Immunol 1991 132 : 158 167
28. Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nature Immunol 2001 2 : 675 680 (Pubitemid 32747155)
29. Alexandroff AB, Jackson AM, James K et al. BCG immunotherapy of bladder cancer: 20 years on. Lancet 1999 353 : 1689 1694